Neurent Medical’s $25 Million Series B Funding Round

Ronan Daly Jermyn and Brown Rudnick advised Neurent Medical on the transaction. Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, has raised…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here